Program Information
Failure Mode and Effect Analysis of Liver Stereotactic Body Radiotherapy
I Rusu1*, T Thomas1 , J Roeske1 , J Price1 , C Perino1 , I Mescioglu2 , M Surucu1 , (1) Loyola University Chicago, Maywood, IL, (2) Lewis University, Romeoville, IL
Presentations
WE-H-BRC-2 (Wednesday, August 3, 2016) 4:30 PM - 6:00 PM Room: Ballroom C
Purpose:
To identify areas of improvement in our liver stereotactic body radiation therapy (SBRT) program, using failure mode and effect analysis (FMEA).
Methods:
A multidisciplinary group consisting of one physician, three physicists, one dosimetrist and two therapists was formed. A process map covering 10 major stages of the liver SBRT program from the initial diagnosis to post treatment follow-up was generated. A total of 102 failure modes, together with their causes and effects, were identified. The occurrence (O), severity (S) and lack of detectability (D) were independently scored. The ranking was done using the risk probability number (RPN) defined as the product of average O, S and D numbers for each mode. The scores were normalized to remove inter-observer variability, while preserving individual ranking order. Further, a correlation analysis on the overall agreement on rank order of all failure modes resulted in positive values for successive pairs of evaluators. The failure modes with the highest RPN value were considered for further investigation.
Results:
The average normalized RPN values for all modes were 39 with a range of 9 to 103. The FMEA analysis resulted in the identification of the top 10 critical failures modes as: Incorrect CT-MR registration, MR scan not performed in treatment position, patient movement between CBCT acquisition and treatment, daily IGRT QA not verified, incorrect or incomplete ITV delineation, OAR contours not verified, inaccurate normal liver effective dose (Veff) calculation, failure of bolus tracking for 4D CT scan, setup instructions not followed for treatment and plan evaluation metrics missed.
Conclusion:
The application of FMEA to our liver SBRT program led to the identification and possible improvement of areas affecting patient safety.
Contact Email: